期刊文献+

Current standard values of health utility scores for evaluating costeffectiveness in liver disease:A meta-analysis 被引量:1

下载PDF
导出
摘要 BACKGROUND Health utility assessments have been developed for various conditions,including chronic liver disease.Health utility scores are required for socio-economic evaluations,which can aid the distribution of national budgets.However,the standard health utility assessment scores for specific health conditions are largely unknown.AIM To summarize the health utility scores,including the EuroQOL 5-dimensions 5-levels(EQ-5D-5L),EuroQol-visual analogue scale,short from-36(SF-36),RAND-36,and Health Utilities Index(HUI)-Mark2/Mark3 scores,for the normal population and chronic liver disease patients.METHODS A systematic literature search of PubMed and MEDLINE,including the Cochrane Library,was performed.Meta-analysis was performed using the RevMan software.Multiple means and standard deviations were combined using the StatsToDo online web program.RESULTS The EQ-5D-5L and SF-36 can be used for health utility evaluations during antiviral therapy for hepatitis C.HUI-Mark2/Mark3 indicated that the health utility scores of hepatitis B patients are roughly 30% better than those of hepatitis C patients.CONCLUSION The EQ-5D-5L is the most popular questionnaire for health utility assessments.Health assessments that allow free registration would be useful for evaluating health utility in patients with liver disease.
出处 《World Journal of Gastroenterology》 SCIE CAS 2022年第31期4442-4455,共14页 世界胃肠病学杂志(英文版)
基金 Supported by Grants-in-Aid from JSPS KAKENHI,No.JP 20K10404(to Mizuguchi T)and No.JP 21K10715(to Ishinuki T) the Hokkaido Hepatitis B Litigation Orange Fund,No.2059198(to Mizuguchi T)and No.2136589(to Harada K) Terumo Life Science Foundation,No.2000666 Pfizer Health Research Foundation,No.2000777 the Viral Hepatitis Research Foundation of Japan,No.3039838 Project Mirai Cancer Research Grants,No.202110251 Takahashi Industrial and Economic Research Foundation,No.12-003-106 Daiichi Sankyo Company,No.2109540 Shionogi and Co.,No.2109493 MSD,No.2099412 Takeda Pharmaceutical Company,No.2000555 Sapporo Doto Hospital,No.2039118 Noguchi Hospital,No.2029083 Doki-kai Tomakomai Hospital,No.2059203 Tsuchida Hospital,No.2000092 Shinyu-kai Noguchi Hospital,No.2029083(to Mizuguchi T) the Yasuda Medical Foundation,No.28-1(to Ishinuki T).
  • 相关文献

参考文献3

二级参考文献6

共引文献14

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部